| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911106 | Lung Cancer | 2014 | 6 Pages |
Abstract
Genetic alterations that are potential targets for molecular targeted therapy were detected in MPM. Amplicon-based massively parallel sequencing was shown to have the advantage of more comprehensive genetic analysis. Further investigation in a larger cohort is necessary to uncover more targetable genetic alterations in MPM and to validate their clinical significance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Takehito Shukuya, Masakuni Serizawa, Masaru Watanabe, Hiroaki Akamatsu, Masato Abe, Hisao Imai, Takaaki Tokito, Akira Ono, Tetsuhiko Taira, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Toshiaki Takahashi, Masahiro Endo, Yasuhisa Ohde,